Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Płużańska · SciRah

Researcher profile · Semantic Scholar

A. Płużańska

Share profile

A. Płużańska — researcher profile on SciRah

h-index: 35
Works: 160
Citations: 18K

Most-cited papers

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer.
I. Tannock, R. de Wit, W. Berry, J. Horti +8 more
2004New England Journal of Medicine5,789 citations
Semantic Scholar
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.
B. Escudier, A. Płużańska, P. Koralewski, A. Ravaud +11 more
2007The Lancet2,276 citations
Semantic Scholar
Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial--INTACT 1.
G. Giaccone, R. Herbst, C. Manegold, G. Scagliotti +14 more
2004Journal of Clinical Oncology1,796 citations Open access
Semantic Scholar
Superior efficacy of letrozole versus tamoxifen as first-line therapy for postmenopausal women with advanced breast cancer: results of a phase III study of the International Letrozole Breast Cancer Group.
H. Mouridsen, M. Gershanovich, Yan Sun, R. Pérez-Carrión +17 more
2001Journal of Clinical Oncology1,048 citations Open access
Semantic Scholar
Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 study group.
F. Fossella, J. R. Pereira, J. von Pawel, A. Płużańska +8 more
2003Journal of Clinical Oncology958 citations
Semantic Scholar
Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
S. Walter, T. Weinschenk, A. Stenzl, R. Zdrojowy +35 more
2012Nature Medicine845 citations
Semantic Scholar
Phase III study of erlotinib in combination with cisplatin and gemcitabine in advanced non-small-cell lung cancer: the Tarceva Lung Cancer Investigation Trial.
U. Gatzemeier, A. Płużańska, A. Szczesna, E. Kaukel +12 more
2007Journal of Clinical Oncology837 citations
Semantic Scholar
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group.
H. Mouridsen, M. Gershanovich, Yan Sun, R. Pérez-Carrión +16 more
2003Journal of Clinical Oncology737 citations
Semantic Scholar
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial.
L. Gianni, U. Dafni, R. Gelber, E. Azambuja +21 more
2011The Lancet Oncology644 citations
Semantic Scholar
Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment.
K. Albain, S. Nag, G. Calderillo-Ruíz, J. P. Jordaan +8 more
2008Journal of Clinical Oncology408 citations Open access
Semantic Scholar
Doxorubicin and paclitaxel versus fluorouracil, doxorubicin, and cyclophosphamide as first-line therapy for women with metastatic breast cancer: final results of a randomized phase III multicenter trial.
J. Jassem, T. Pieńkowski, A. Płużańska, S. Jelić +8 more
2001Journal of Clinical Oncology322 citations
Semantic Scholar
A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC).
K. Roszkowski, A. Płużańska, M. Krzakowski, A. Smith +6 more
2000Lung Cancer299 citations
Semantic Scholar
Docetaxel compared with sequential methotrexate and 5-fluorouracil in patients with advanced breast cancer after anthracycline failure: a randomised phase III study with crossover on progression by the Scandinavian Breast Group.
J. Sjöström, C. Blomqvist, H. Mouridsen, A. Płużańska +9 more
1999European Journal of Cancer292 citations
Semantic Scholar
Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC)
U. Gatzemeier, A. Płużańska, A. Szczesna, E. Kaukel +5 more
2004267 citations
Semantic Scholar
Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.
B. Górski, T. Byrski, T. Huzarski, A. Jakubowska +8 more
2000American Journal of Human Genetics267 citations Open access
Semantic Scholar
Phase III trial of liposomal doxorubicin and cyclophosphamide compared with epirubicin and cyclophosphamide as first-line therapy for metastatic breast cancer.
Stephen Chan, N. Davidson, E. Juozaitytė, F. Erdkamp +3 more
2004Annals of Oncology154 citations Open access
Semantic Scholar
First-line bevacizumab combined with reduced dose interferon-alpha2a is active in patients with metastatic renal cell carcinoma.
B. Melichar, P. Koralewski, A. Ravaud, A. Płużańska +11 more
2008Annals of Oncology118 citations Open access
Semantic Scholar
A randomized, controlled, double-blind phase III study (AVOREN) of bevacizumab/interferon-α2a vs placebo/interferon- α2a as first-line therapy in metastatic renal cell carcinoma
B. Escudier, P. Koralewski, A. Płużańska, A. Ravaud +6 more
200799 citations
Semantic Scholar
Evaluation of clinical significance of TP53, BCL-2, BAX and MEK1 expression in 229 ovarian carcinomas treated with platinum-based regimen
J. Kupryjańczyk, T. Szymanska, R. Mądry, A. Timorek +18 more
2003British Journal of Cancer95 citations Open access
Semantic Scholar
Results of a phase III trial of erlotinib (OSI-774) combined with cisplatin and gemcitabine (GC) chemotherapy in advanced non-small cell lung cancer (NSCLC).
U. Gatzemeier, A. Płużańska, A. Szczesna, E. Kaukel +5 more
2004Journal of Clinical Oncology91 citations
Semantic Scholar
Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer.
M. Luoma, L. Hakamies-blomqvist, J. Sjöström, A. Płużańska +8 more
2003European Journal of Cancer83 citations
Semantic Scholar
Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution.
P. Smolewski, T. Robak, E. Krykowski, M. Błasińska-Morawiec +4 more
2000Clinical Cancer Research73 citations
Semantic Scholar
P21WAF1, P27KIP1, TP53 and C-MYC analysis in 204 ovarian carcinomas treated with platinum-based regimens.
Joanna Plisiecka-Hałasa, G. Karpińska, T. Szymanska, I. Ziółkowska +20 more
2003Annals of Oncology64 citations Open access
Semantic Scholar
Effect of chemotherapy for advanced non-small cell lung cancer on patients' quality of life. A randomized controlled trial.
C. Belani, J. R. Pereira, J. von Pawel, A. Płużańska +8 more
2006Lung Cancer62 citations
Semantic Scholar
A multicenter, randomized phase III study of docetaxel + cisplatin (DC) vs docetaxel + carboplatin (DCb) vs vinorelbine + cisplatin (VC) in chemotherapy-naive patients (Pts) with advanced and metastatic non-small cell lung cancer (NSCLC)
C. Belani, J. Rodriguez, J. von Pawel, A. Płużańska +8 more
200061 citations
Semantic Scholar
Hereditary ovarian cancer in Poland.
J. Menkiszak, J. Gronwald, B. Górski, A. Jakubowska +30 more
2004International Journal of Cancer58 citations
Semantic Scholar
Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19.
L. Reyno, L. Seymour, D. Tu, S. Dent +14 more
2004Journal of Clinical Oncology58 citations
Semantic Scholar
Two different first-line 5-fluorouracil regimens with or without oxaliplatin in patients with metastatic colorectal cancer.
D. Cunningham, B. Sirohi, A. Płużańska, B. Utracka-Hutka +12 more
2009Annals of Oncology56 citations Open access
Semantic Scholar
A multicenter phase III comparison of docetaxel (D) + prednisone (P) and mitoxantrone (MTZ) + P in patients with hormone-refractory prostate cancer (HRPC).
M. Eisenberger, R. de Wit, William R. Berry, I. Bodrogi +6 more
2004Journal of Clinical Oncology52 citations
Semantic Scholar
A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer
E. Tan, R. Ramlau, A. Płużańska, H. Kuo +14 more
2010Annals of Oncology44 citations Open access
Semantic Scholar
Timing of quality of life (QoL) assessments as a source of error in oncological trials.
L. Hakamies-blomqvist, M. Luoma, J. Sjöström, A. Płużańska +8 more
2001Journal of Advanced Nursing44 citations
Semantic Scholar
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group.
L. Hakamies-blomqvist, M. Luoma, J. Sjöström, A. Płużańska +8 more
2000European Journal of Cancer43 citations
Semantic Scholar
The role of intratumoral therapy with cisplatin/epinephrine injectable gel in the management of advanced squamous cell carcinoma of the head and neck.
B. Wenig, J. Werner, D. Castro, K. Sridhar +9 more
2002Archives of Otolaryngology - Head and Neck Surgery40 citations Open access
Semantic Scholar
TP53 status determines clinical significance of ERBB2 expression in ovarian cancer
J. Kupryjańczyk, R. Mądry, Joanna Plisiecka-Hałasa, J. Bar +11 more
2004British Journal of Cancer37 citations Open access
Semantic Scholar
Hereditary ovarian cancer in Poland
J. Menkiszak, J. Gronwald, B. Górski, A. Jakubowska +30 more
200335 citations
Semantic Scholar
Intermittent 2-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic leukemia.
T. Robak, M. Błasinka-Morawiec, E. Krykowski, M. Kasznicki +21 more
2009Leukemia and Lymphoma30 citations
Semantic Scholar
Glutathione and glutathione metabolizing enzymes in tissues and blood of breast cancer patients.
J. Gromadzińska, W. Wąsowicz, M. Andrijewski, M. Skłodowska +4 more
1997Neoplasma (Bratislava)26 citations
Semantic Scholar
A phase III placebo-controlled study in advanced head and neck cancer using intratumoural cisplatin/epinephrine gel
J. Werner, W. Kehrl, A. Płużańska, O. Arndt +8 more
2002British Journal of Cancer24 citations Open access
Semantic Scholar
Doxorubicin and Paclitaxel versus Fluorouracil, Doxorubicin and Cyclophosphamide as First-Line Therapy for Women with Advanced Breast Cancer: Long-Term Analysis of the Previously Published Trial
J. Jassem, T. Pieńkowski, A. Płużańska, S. Jelić +7 more
2009Oncology Research and Treatment17 citations
Semantic Scholar
Final results of a randomized phase III study evaluating the addition of oxaliplatin first line to 5-FU followed by irinotecan at progression in advanced colorectal cancer (LIFE study)
A. Płużańska, P. Mainwaring, J. Cassidy, B. Utracka-Hutka +6 more
200517 citations
Semantic Scholar
Physical Performance, Toxicity, and Quality of Life as Assessed by the Physician and the Patient
M. Luoma, L. Hakamies-blomqvist, J. Sjöström, H. Mouridsen +11 more
2002Acta oncologica14 citations Open access
Semantic Scholar
Randomized double-blind placebo-controlled international trial of abagovomab maintenance therapy in patients with advanced ovarian cancer after complete response to first-line chemotherapy: The Monoclonal Antibody Immunotherapy for Malignancies of the Ovary by Subcutaneous Abagovomab (MIMOSA) trial.
J. Pfisterer, J. Berek, A. Casado, K. Cwiertka +9 more
2011Journal of Clinical Oncology11 citations
Semantic Scholar
Abagovomab maintenance therapy in patients with epithelial ovarian cancer after complete response (CR) post-first-line chemotherapy (FLCT): Preliminary results of the randomized, double-blind, placebo-controlled, multicenter MIMOSA trial.
P. Sabbatini, J. Berek, A. Casado, K. Cwiertka +6 more
201011 citations
Semantic Scholar
4518 POSTER First-line bevacizumab improves progression-free survival with lower doses of interferon-a2a in the treatment of patients with metastatic renal cell carcinoma (AVOREN)
B. Melichar, P. Koralewski, A. Płużańska, A. Ravaud +6 more
20078 citations
Semantic Scholar
4008 POSTER Bevacizumab/interferon-alpha2a provides a progression-free survival benefit in all prespecified patient subgroups as first-line treatment of metastatic renal cell carcinoma (AVOREN)
S. Bracarda, P. Koralewski, A. Płużańska, A. Ravaud +6 more
20077 citations
Semantic Scholar
Lipid Peroxide Levels and Antioxidant Enzyme Activities in Blood of Breast Cancer Patients
J. Gromadzińska, M. Skłodowska, Piotr Wolkanin, W. Wąsowicz +2 more
19926 citations Open access
Semantic Scholar
Local immunotherapy with propionibacterium granulosum KP-45 in advanced breast cancer.
A. Płużańska, J. Stempczynska, S. Szmigielski, M. Luczak +2 more
1985Anticancer Research6 citations
Semantic Scholar
Palonosetron (PALO), administered orally or intravenously (IV), plus dexamethasone for prevention of chemotherapy-induced nausea and vomiting (CINV)
R. Boccia, E. F. González, A. Płużańska, G. Clerici
20085 citations
Semantic Scholar
D2-04: MERIT: a prospective study of putative relationships between tumour biomarkers and clinical benefit from erlotinib in advanced non-small cell lung cancer (NSCLC)
E. Tan, R. Ramlau, A. Płużańska, H. Kuo +6 more
20075 citations Open access
Semantic Scholar
[Pharmacological action of paclitaxel].
P. Potemski, A. Płużańska
1999Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego5 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Koralewski×7
Invite
P. Koralewski — researcher profile on SciRah
C. Szczylik×7
Invite
C. Szczylik — researcher profile on SciRah
J. von Pawel×7
Invite
J. von Pawel — researcher profile on SciRah
A. Ravaud×5
Invite
A. Ravaud — researcher profile on SciRah

×5

Invite

S. Bracarda — researcher profile on SciRah

Invite

C. Chevreau — researcher profile on SciRah

Invite

B. Melichar — researcher profile on SciRah

Invite

E. Kaukel — researcher profile on SciRah

Invite

R. Ramlau — researcher profile on SciRah

Invite

A. Szczesna — researcher profile on SciRah

J. Sjöström×5

Invite

J. Sjöström — researcher profile on SciRah

C. Blomqvist×5

Invite

C. Blomqvist — researcher profile on SciRah